Diverse neurological effects linked to anti-PD-1 therapy

September 11, 2017

(HealthDay)—Neurological complications associated with anti-programmed death 1 (PD-1) antibody treatment have a diverse phenotype, according to a study published online Sept. 5 in JAMA Neurology.

Justin C. Kao, M.B.Ch.B., from the Mayo Clinic in Rochester, Minnesota, and colleagues conducted a involving patients with development of neurological symptoms within 12 months of receiving anti-PD-1 therapy.

The researchers found that 2.9 percent of the 347 patients treated with anti-PD-1 monoclonal antibodies developed subacute onset of . Seven of these patients received pembrolizumab and three nivolumab. Neurological complications occurred after a median of 5.5 anti-PD-1 inhibitor cycles. Myopathy, varied neuropathies, cerebellar ataxia, autoimmune retinopathy, bilateral internuclear ophthalmoplegia, and headache were reported complications. Reported were axonal and demyelinating polyradiculoneuropathies, length-dependent neuropathies, and asymmetric vasculitic neuropathy.

"Neurological adverse events associated with anti-PD-1 therapy have a diverse phenotype, with more frequent neuromuscular complications," the authors write. "Prompt recognition and discontinuation of anti-PD-1 is recommended. In some cases, immune rescue treatment may be required."

One author disclosed financial ties to the pharmaceutical industry.

Explore further: Melanoma therapy tied to cutaneous adverse events

More information: Abstract/Full Text
Editorial

Related Stories

Melanoma therapy tied to cutaneous adverse events

March 16, 2016
(HealthDay)—Anti-programmed cell death (PD)-1 therapy for metastatic melanoma is associated with the development of immune-related cutaneous events, according to research published in the March issue of the Journal of the ...

Skin lesions for 29 percent with anti-TNF treatment in IBD

December 8, 2015
(HealthDay)—For patients with inflammatory bowel disease treated with anti-tumor necrosis factor (TNF) therapy, skin lesions frequently develop but rarely necessitate treatment discontinuation, according to research published ...

Transvenous pacemaker complications common, costly

August 31, 2017
(HealthDay)—The incidence of complications for single- and dual-chamber transvenous pacemakers (TVPs) is considerable, reaching about 15 and 16 percent, respectively, by three years, with high associated costs, according ...

Majority of derm clinic patients express interest in anti-aging tx

August 14, 2017
(HealthDay)—Patients are largely unfamiliar with most anti-aging treatment options, but are interested in pursuing future treatment, according to a study published online Aug. 3 in the Journal of Cosmetic Dermatology.

No advantage of ambulance over hospital anti-clot therapy for heart attack patients

August 29, 2017
In contrast to European and American guidelines that recommend pre-hospital antiplatelet therapy for heart attack patients suffering from ST-elevation myocardial infarction (STEMI), a new study presented at ESC Congress suggests ...

Responses to treatment, outcomes of autoimmune cerebellar ataxia

September 28, 2015
While autoimmune cerebellar ataxia (a loss of muscle coordination) can lead to severe disability with some patients becoming wheelchair-bound, there are factors that may help to predict better immunotherapy response and neurological ...

Recommended for you

Researchers discover novel mode of neurotransmitter-based communication

May 21, 2018
Researchers at the University of California, Irvine School of Medicine have discovered the first example of a novel mode of neurotransmitter-based communication. The discovery, published in Nature Communications, challenges ...

Mice regrow brain tissue after stroke with bioengineered gel

May 21, 2018
In a first-of-its-kind finding, a new stroke-healing gel helped regrow neurons and blood vessels in mice with stroke-damaged brains, UCLA researchers report in the May 21 issue of Nature Materials.

Reading the minds of pilots on the fly

May 21, 2018
After a plane engine blew apart at 32,000 feet in the air last month, the pilot flying Southwest Flight 1380 safely brought the Boeing 737 to an emergency landing in Philadelphia. Captain Tammie Jo Shults was heralded a hero, ...

Vascular risk interacts with amyloid levels to increase age-related cognitive decline

May 21, 2018
Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain. Vascular risk factors increase ...

Casting light on better bowels

May 21, 2018
A novel light therapy is being investigated as an alternative to prescription drugs to relieve chronic constipation and other intestinal disorders which affect millions of patients around the world.

How social isolation transforms the brain

May 17, 2018
Chronic social isolation has debilitating effects on mental health in mammals—for example, it is often associated with depression and post-traumatic stress disorder in humans. Now, a team of Caltech researchers has discovered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.